Purchase Order 75N92024P00111
Award Date 3/19/24
Potential Completion Date 3/18/25
Potential Value $102K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute (NHLBI) awarded a $15,649.12 firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) for the delivery of reagents to support genetic sequencing and analysis of myeloid cell mutations. IDT, a manufacturer of nucleic acid products for the life sciences industry, has previously supported federal agencies such as the National Institutes of Health, Centers for Disease...
- Integrated DNA Technologies, Inc., doing business as IDT, has been awarded a $21,320 firm fixed price purchase order by the National Institutes of Health's National Center for Advancing Translational Sciences to provide unspecified products or services. The contract has a period of performance from July 14, 2023 through July 31, 2023 at IDT's place of performance in Coralville, Iowa. No additional details were provided regarding the original solicitation, though NCATS supports early-stage...
- Integrated DNA Technologies, Inc. (IDT), headquartered in Coralville, Iowa, received a contract award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) for custom oligonucleotides valued at $14,638.50. Issued on March 24, 2016, this Blanket Purchase Agreement (BPA) call was awarded on a firm fixed-price basis with an ultimate completion date of August 31, 2016. The contract was not designated as a set-aside procurement, indicating IDT competed in an open...
- This federal contract award, valued at $23,724.00, was issued by the National Heart Lung and Blood Institute to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. government. The contract is for the supply of custom DNA sequencing library reagents to support the laboratory's efforts to detect and quantify the frequency of AML-associated mutations in patient samples. This is a firm-fixed-price purchase order, with no set-aside...
- Integrated DNA Technologies, Inc. (IDT), headquartered in Coralville, Iowa, was awarded a $19,858 Blanket Purchase Agreement (BPA) call by the National Institute of Environmental Health Sciences (NIEH), a civilian agency within the National Institutes of Health. This firm-fixed-price contract, awarded on August 31, 2022, with an ultimate completion date of August 31, 2023, represents a call against an existing BPA vehicle. The contract carries no set-aside designation, reflecting IDT's...
- The U.S. National Institutes of Health (NIH) awarded a $12,712.97 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide a 3-month supply of reagents for exome sequencing at the NIH Intramural Sequencing Center (NISC), a centralized research facility for high-throughput DNA sequencing and analysis. IDT, a leading manufacturer of specialized nucleic acid products, has supported a variety of federal agencies through prime contracts and subcontracts, including the...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $14,592.70 firm fixed price purchase order to Integrated DNA Technologies, Inc. doing business as IDT. Under this contract, IDT will provide 2S PLUS DNA Library Kits in the quantity of 96 reactions to support the agency's genomic research efforts. Place of performance will be IDT's facilities in Coralville, Iowa, with work expected to be completed by September 30, 2023. No...
- Integrated DNA Technologies, Inc. (IDT) has been awarded a $11,154.14 firm-fixed-price purchase order by the U.S. Department of the Interior Fish and Wildlife Service to provide 96-well plates for the agency's National Forensics Laboratory in Coralville, Iowa. IDT will deliver the requested nucleic acid products by May 31, 2024. As a manufacturer of custom DNA and RNA oligonucleotides and reagents for research and clinical applications, IDT is well positioned to support the laboratory's work...
- This firm-fixed-price purchase order for $114,787.00 was awarded by the National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide the ARCHERDx VariantPlex System. The award has no set-aside designation and is expected to be completed by June 23, 2025. IDT is a major provider of specialized nucleic acid products and services to federal agencies. The company frequently supports pandemic...
- This is a firm fixed-price contract awarded by the National Heart Lung and Blood Institute, an agency of the Department of Health and Human Services, to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides needed to support an antibody association study project. The $16,494.25 contract is a Blanket Purchase Agreement (BPA) call and does not utilize any set-aside designations, indicating IDT competed effectively in the open market. IDT is a leading manufacturer and supplier of...
Integrated DNA Technologies, Inc. (IDT) has been awarded a firm fixed price purchase order totaling $101,976 by the National Institutes of Health National Heart Lung and Blood Institute to supply reagents for the sequencing of bone marrow failure syndromes. IDT will deliver the requested products from its place of performance in Coralville, Iowa in support of the agency's research into these conditions. No set-aside designation was applied to this procurement. IDT has an established record of providing specialized nucleic acid products to government customers including the National Institutes of Health and other Department of Health and Human Services components to enable critical diagnostic, research, and pandemic response applications.
Generated 3/15/24, 10:52 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $102.0k | 3/14/24 |